Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urologic Endoscopic Procedure: Cystoscopic Examination01:28

Urologic Endoscopic Procedure: Cystoscopic Examination

467
Meaning of Cystoscopic Examination:Cystoscopy is an essential diagnostic tool in urology that is used to assess the structure and function of the genitourinary system. It provides a direct view of the urethra, bladder, and, in some cases, the ureteral openings. This procedure helps detect structural abnormalities, infections, cancers, and blockages in the urinary tract. There are two types of cystoscopy:Flexible cystoscopy is commonly performed in outpatient settings due to its less invasive...
467
Uterus and Cervix01:18

Uterus and Cervix

2.3K
The uterus, commonly called the womb, is a vital reproductive organ in females designed to provide a nurturing environment for the implantation and growth of an embryo. It is shaped like a hollow pear and positioned between the urinary bladder and the rectum. The uterus's structure allows it to support and protect a developing fetus throughout pregnancy.
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Communication patterns among surgical pathologists: a retrospective review of ideal strategies in a tertiary care setting.

American journal of clinical pathology·2026
Same author

Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer.

Nature communications·2026
Same author

Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma.

Nature communications·2026
Same author

Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer.

Genome biology·2026
Same author

[<sup>177</sup>Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study.

The Lancet. Oncology·2026
Same author

Reply to: The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells.

medRxiv : the preprint server for health sciences·2025
Same journal

Invasive urothelial carcinoma in association with surface low-grade papillary urothelial carcinoma: clinical and pathologic insights from a rare entity.

American journal of clinical pathology·2026
Same journal

CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.

American journal of clinical pathology·2026
Same journal

Comprehensive multicriteria life cycle assessment of biopsy processing in a surgical pathology department.

American journal of clinical pathology·2026
Same journal

Prognostic significance of Myb protein and its downstream target genes in lacrimal gland adenoid cystic carcinoma.

American journal of clinical pathology·2026
Same journal

Mismatch repair protein "nonclassic expression loss" pattern in colorectal cancer: an important staining pattern that is not well understood.

American journal of clinical pathology·2026
See all related articles

Related Experiment Video

Updated: Sep 23, 2025

Isolation and Flow Cytometric Analysis of Human Endocervical Gamma Delta T Cells
08:10

Isolation and Flow Cytometric Analysis of Human Endocervical Gamma Delta T Cells

Published on: February 6, 2017

8.9K

Adequacy in Endocervical Curettage.

Roa Alqabbani1, Joanna Chan1, Allison Goldberg1

  • 1Department of Pathology, Thomas Jefferson University Hospital, Philadelphia, PA, USA.

American Journal of Clinical Pathology
|May 15, 2022
PubMed
Summary
This summary is machine-generated.

Adequate cellularity for diagnosing high-grade dysplasia (HGD) in endocervical curettage (ECC) specimens is approximately 10,000 cells. Lower cellularity, around 1,000 cells, is considered inadequate for accurate HGD diagnosis on ECC.

Keywords:
Endocervical curettageHigh-grade dysplasiaPapanicolaou test

More Related Videos

Collection, Isolation, and Flow Cytometric Analysis of Human Endocervical Samples
12:34

Collection, Isolation, and Flow Cytometric Analysis of Human Endocervical Samples

Published on: July 6, 2014

19.3K
Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
03:01

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity

Published on: August 2, 2024

883

Related Experiment Videos

Last Updated: Sep 23, 2025

Isolation and Flow Cytometric Analysis of Human Endocervical Gamma Delta T Cells
08:10

Isolation and Flow Cytometric Analysis of Human Endocervical Gamma Delta T Cells

Published on: February 6, 2017

8.9K
Collection, Isolation, and Flow Cytometric Analysis of Human Endocervical Samples
12:34

Collection, Isolation, and Flow Cytometric Analysis of Human Endocervical Samples

Published on: July 6, 2014

19.3K
Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
03:01

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity

Published on: August 2, 2024

883

Area of Science:

  • Gynecologic Pathology
  • Cervical Cancer Screening
  • Histopathology Quality Assurance

Background:

  • Specimen adequacy is crucial for Papanicolaou tests, but criteria for endocervical curettage (ECC) are lacking.
  • High-grade dysplasia (HGD) diagnosis relies on accurate cellularity assessment.
  • Establishing cellularity benchmarks for ECC is essential for quality assurance.

Purpose of the Study:

  • To determine the minimum acceptable cellularity for diagnosing HGD in ECC specimens.
  • To evaluate the role of p16 immunohistochemistry (IHC) in conjunction with ECC findings.
  • To provide evidence-based criteria for ECC specimen adequacy.

Main Methods:

  • Retrospective analysis of 51 patients with HGD diagnosed via loop electrosurgical excision procedure (LEEP) and preceding ECC.
  • Quantification of squamous cell cellularity in ECC specimens using Aperio eSlide Manager.
  • Comparison of cellularity between positive and negative ECCs for HGD using t-tests and IHC staining for p16 using chi-squared tests.

Main Results:

  • ECC specimens positive for HGD showed significantly higher cellularity (mean 10,165 cells) than negative specimens (mean 1,055 cells).
  • p16 IHC was more frequently applied to HGD-positive ECCs (50%) versus HGD-negative ECCs (3%).
  • Biopsies with negative ECC findings were more likely to undergo p16 IHC (51%) than those with positive ECC findings (7%).

Conclusions:

  • Approximately 10,000 cells are adequate, while 1,000 cells are inadequate for diagnosing HGD in ECC specimens.
  • p16 IHC is utilized as a 'rule-in' test for ECC, but its interpretation requires careful consideration of concurrent biopsy results.
  • Further research into laboratory techniques to optimize ECC cellularity is recommended.